JPH023611A - Method for manufacturing a solid composition of lacturose and a composition obtained by this method - Google Patents
Method for manufacturing a solid composition of lacturose and a composition obtained by this methodInfo
- Publication number
- JPH023611A JPH023611A JP1038475A JP3847589A JPH023611A JP H023611 A JPH023611 A JP H023611A JP 1038475 A JP1038475 A JP 1038475A JP 3847589 A JP3847589 A JP 3847589A JP H023611 A JPH023611 A JP H023611A
- Authority
- JP
- Japan
- Prior art keywords
- lactulose
- mixture
- syrup
- composition
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
この発明は、ラクッロース投与用固体組成物の製造方法
及びこの方法により得られる組成物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a solid composition for administration of laculose and a composition obtained by this method.
ラクツロース、ラクトースの異性化生成物、がなかんず
く慢性便秘及び肝性昏睡の治療に特に適することが知ら
れている。通常、ラクッロースの50%水溶液の形のラ
クッロースが使用される。しかし、このようなシロップ
の形のラクッロースの使用は理想からはるかに遠い。It is known that lactulose, the isomerization product of lactose, is particularly suitable for the treatment of chronic constipation and hepatic coma, among others. Typically, laculose in the form of a 50% aqueous solution of laculose is used. However, the use of laculose in the form of such a syrup is far from ideal.
更に、結晶形のラクッロースの使用が知られている。し
かし、ラクッロースの結晶化方法は、特に面倒である。Furthermore, the use of laculose in crystalline form is known. However, the method of crystallization of laculose is particularly laborious.
Q後に、英国特許出願第2156196号が植物繊維と
ラクツロースを含む治療又は食事療法用の組成物に関す
る。この二つの成分は、強い逆の相乗効果を示すべきで
ある。このMll動物使用される植物繊維又は食事療法
繊維は、「生繊維(rawfibre)、1の「活性」
繊維として知られている11〜22%の繊維を含有する
。多数の他の成分によってこの既知3■成物は、食事療
法製品、特にビスケットの形に加工することができる。After Q, British Patent Application No. 2,156,196 relates to therapeutic or dietary compositions comprising vegetable fibers and lactulose. The two components should exhibit strong opposing synergistic effects. The plant fiber or dietary fiber used in this Mll animal is ``raw fiber'', an ``active'' fiber of 1
Contains 11-22% fibers known as fibres. With a number of other ingredients, this known three-part composition can be processed into dietary products, especially in the form of biscuits.
この発明の目的は、ラクツロース投与用固体kli成物
の容易な!!!造方法を提、供することである。It is an object of this invention to provide a ready-to-use solid KLI formulation for lactulose administration. ! ! The goal is to provide a method for creating a product.
ラクツロース投与用固体組成物は、ラクツロースシロッ
プ用担体としての吸湿性繊維製品上にラクッロースシロ
ップを加えることにより得ることができることを確かめ
た。従来使用された薬液用1■休材料、例えば、エーロ
ゾル、ラクトース及び(:alll’Oaは、この目的
に対して適当でないことが分かった。It has been found that a solid composition for lactulose administration can be obtained by adding lactulose syrup onto a hygroscopic textile as a carrier for lactulose syrup. It has been found that the previously used pharmaceutical ingredients, such as aerosols, lactose and all'Oa, are not suitable for this purpose.
また、植物繊♀II!物質(すなわち、生繊維)も、ラ
クッロース投与用固体組成物の製造用吸湿性担体として
使用することができない。Also, plant fiber ♀ II! The material (ie raw fiber) also cannot be used as a hygroscopic carrier for the manufacture of solid compositions for administration of laculose.
ファイバーフオーム(Fiberform)■として知
られる、80重星%を超える繊維含■を有する、穀粒の
殻(husk)に基づく食物繊維製品がラクツロースシ
ロップからラクツロース投与用の適当な固体S■成物を
簡単な仕方で製造するために担体材料として極めて良好
に使用されうることを特に6■かめた。ファイバーフオ
ームは、腸の活動を制御する薬剤として使用される。こ
れは、選択的3段階酵素発酵方法によるコムギふすま(
wheat bran)から製造される調整された繊維
濃縮物の粒質物である。第1段(タンパク質加水分解)
においてタンパク質含量をプロテイナーゼにより低減す
る。第2段(デンプン消化)において生成物をアミラー
ゼで処理して実際的にすべてのデンプンを除く。A dietary fiber product based on the husk of grains with a fiber content of greater than 80%, known as Fiberform, converts lactulose syrup into a suitable solid S composition for lactulose administration. It has been found in particular that it can be used very well as a carrier material for production in a simple manner. Fiberforms are used as agents to control intestinal activity. It is produced from wheat bran (
A granulate of a modified fiber concentrate made from wheat bran. 1st stage (protein hydrolysis)
The protein content is reduced by proteinases. In the second stage (starch digestion) the product is treated with amylase to remove virtually all starch.
第3段(フィチン酸の除去)において自然に存在する酵
素フィツーゼを活性化して鉄、亜鉛、カルシラ11及び
マグネシウムのような必須ミネラルと結合することが知
られるフィチン酸の90%を超える星を分解除去する。In the third stage (phytic acid removal), the naturally occurring enzyme phytose is activated to break down over 90% of the phytic acid, which is known to combine with essential minerals like iron, zinc, calcila-11 and magnesium. Remove.
得られた粒質物は、標準化された、再現性のある医薬特
性を有する。The resulting granulate has standardized and reproducible pharmaceutical properties.
この発明に従うラクツロース投与用固体組成物は、ラク
ツロースシロップをファイバーフオーム担体材料と混合
し、混合物を広げ、乾燥し、砕き任意にふるい分けて所
望の粒度にすることにより簡単な仕方で得られる。The solid composition for lactulose administration according to the invention is obtained in a simple manner by mixing lactulose syrup with a fiber foam carrier material, spreading the mixture, drying, crushing and optionally sieving to the desired particle size.
好ましい出発物質は、約50%の固体ラクツロースを含
有するシロップである。このシロップのリットル当りフ
ァイバーフオーム150〜350g、特に200〜30
0gの星が使用される。混合物を数分間混合し、ステン
レス鋼プレート上に広げる。60〜90℃1好ましくは
約80℃の温度で数時間乾燥した後、得られた生成物を
、例えば、振動造粒装置中で砕き、Q後に、所要に応じ
て、所望の粒度にふるい分ける。A preferred starting material is a syrup containing about 50% solid lactulose. 150-350 g of fiber foam per liter of this syrup, especially 200-30 g
A 0g star is used. Mix the mixture for a few minutes and spread it on a stainless steel plate. After drying for several hours at a temperature of 60 to 90 °C, preferably about 80 °C, the product obtained is crushed, for example in a vibratory granulator, and after Q, if necessary, sieved to the desired particle size. .
この発明に従うラクツロースの固体1■成物の製造には
、他の補助物質が不必要であり、これは、医薬製品にと
って利点である。The production of a solid one-part composition of lactulose according to the invention does not require any other auxiliary substances, which is an advantage for pharmaceutical products.
ラクッロース投与用固体組成物をこのように簡単な仕方
でIjることができるのは、極めて驚くべきことである
。It is quite surprising that a solid composition for administration of laculose can be prepared in such a simple manner.
■
食物繊維製品ファイバーフオーム7.5kgをラクツロ
ース溶液(ジュファラック(Duphalac)■32
kgとコレ・ンテ(Co I le t te)
ミニ1−ザー中で5分間混合した。混合物を20枚の「
密閉」乾燥プレート上に分配し100℃の入口空気で6
時間乾燥した。それぞれ2時間及び4時間乾燥後、塊を
ほぐした。乾燥塊を1 、5mmのふるい格子を有する
フリユイツト造粒装置(Frewi LL 12ran
ulator)によって砕いた。■ 7.5 kg of dietary fiber product Fiberform was added to a lactulose solution (Duphalac) ■32
kg and cole te
Mixed for 5 minutes in a mini-zer. Spread the mixture into 20 sheets.
6. Distribute onto a sealed drying plate and inlet air at 100 °C.
Dry for an hour. After drying for 2 and 4 hours, respectively, the clumps were loosened. The dry mass was transferred to a Frewi LL 12ran granulator (Frewi LL 12ran) with a sieve grid of 5 mm.
ulator).
Claims (1)
ームと混合し、混合物を広げ、乾燥し、砕き、任意にふ
るい分けることを特徴とするラクツロースの固体組成物
の製造方法。 2、50%ラクツロースシロップを該シロップのリット
ル当り150〜350gの量のファイバーフォームと混
合する請求項1載記の製造方法。 3、ラクツロースシロップリットル当り200〜300
gのファイバーフォームを使用する請求項2記載の製造
方法。 4、ラクツロースシロップとファイバーフォームとの混
合物を数分間混合し、広げ、60〜90℃で数時間乾燥
し、固体生成物を砕き任意にふるい分ける請求項1ない
し請求項3のいずれか一つの項に記載の製造方法。 5、乾燥を80℃で6時間行う請求項4記載の製造方法
。 6、請求項1ないし請求項5のいずれか一つの項に記載
の製造方法に従って得られるラクツロースとファイバー
フォームの固体組成物。Claims: 1. A process for producing a solid composition of lactulose, characterized in that lactulose syrup is mixed with a high fiber product fiber foam, the mixture is spread, dried, crushed and optionally sieved. 2. Process according to claim 1, characterized in that 50% lactulose syrup is mixed with fiber foam in an amount of 150 to 350 g per liter of syrup. 3. Lactulose syrup 200-300 per liter
3. The manufacturing method according to claim 2, wherein the fiber foam of g. 4. The mixture of lactulose syrup and fiber foam is mixed for several minutes, spread, dried at 60-90°C for several hours, and the solid product is crushed and optionally sieved. The manufacturing method described in. 5. The manufacturing method according to claim 4, wherein drying is performed at 80° C. for 6 hours. 6. A solid composition of lactulose and fiber foam obtained according to the production method according to any one of claims 1 to 5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8800431 | 1988-02-22 | ||
| NL8800431 | 1988-02-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH023611A true JPH023611A (en) | 1990-01-09 |
| JP3044046B2 JP3044046B2 (en) | 2000-05-22 |
Family
ID=19851826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1038475A Expired - Lifetime JP3044046B2 (en) | 1988-02-22 | 1989-02-20 | Method for producing solid composition of lactulose and composition obtained by this method |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4931554A (en) |
| EP (1) | EP0334407B1 (en) |
| JP (1) | JP3044046B2 (en) |
| AT (1) | ATE92308T1 (en) |
| AU (1) | AU620846B2 (en) |
| CA (1) | CA1319615C (en) |
| DE (1) | DE68907965T2 (en) |
| DK (1) | DK72989A (en) |
| ES (1) | ES2058467T3 (en) |
| IE (1) | IE62727B1 (en) |
| IL (1) | IL89344A (en) |
| NZ (1) | NZ228021A (en) |
| ZA (1) | ZA891266B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5105100A (en) * | 1990-06-29 | 1992-04-14 | Nec Corporation | Easily and quickly testable master-slave flipflop circuit |
| JP2019154340A (en) * | 2018-03-14 | 2019-09-19 | 森永乳業株式会社 | Dried lactulose, edible composition, and production method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2808292A (en) * | 1955-03-21 | 1957-10-01 | Melnor Metal Products Co Inc | Fluid-actuated oscillatable lawn sprinkler |
| ZA891978B (en) * | 1988-03-18 | 1990-01-31 | Duphar Int Res | Method of preparing solid lactulose |
| DK249789A (en) * | 1988-05-26 | 1989-11-27 | Duphar Int Res | PREPARATION WITH ANTI-ENDOTOXIC ACTIVITY |
| FR2673812B1 (en) * | 1991-03-13 | 1994-04-01 | Roussel Uclaf | NOVEL COMPOSITIONS FOR USE IN DIETETICS AND THERAPEUTICS AND CONTAINING A PARTICULAR COMBINATION OF CARBOHYDRATES AND THEIR APPLICATIONS. |
| KR19980702782A (en) * | 1995-03-09 | 1998-08-05 | 혼 마가렛 에이. | Starch Liquefaction Method |
| US5651988A (en) * | 1995-08-18 | 1997-07-29 | Xyrofin Oy | Combination osmotic and bulk forming laxatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3110600A (en) * | 1960-04-22 | 1963-11-12 | Tervalon Nv | Method of drying a lactulosecontaining aqueous liquid |
| JPS4944331B1 (en) * | 1971-05-31 | 1974-11-27 | ||
| IE48036B1 (en) * | 1977-10-18 | 1984-09-05 | Nordstjernan Ab | Process for the preparation of a hydrolysed product from whole corn,and such a product |
| IT1173497B (en) * | 1984-03-28 | 1987-06-24 | Farmaco Italiano Padil Srl | COMPOSITIONS BASED ON VEGETABLE FIBER AND ALTTULOSE |
-
1989
- 1989-02-17 CA CA000591404A patent/CA1319615C/en not_active Expired - Fee Related
- 1989-02-17 US US07/311,953 patent/US4931554A/en not_active Expired - Fee Related
- 1989-02-17 NZ NZ228021A patent/NZ228021A/en unknown
- 1989-02-17 ZA ZA891266A patent/ZA891266B/en unknown
- 1989-02-17 IE IE51389A patent/IE62727B1/en not_active IP Right Cessation
- 1989-02-17 DK DK072989A patent/DK72989A/en not_active Application Discontinuation
- 1989-02-20 IL IL89344A patent/IL89344A/en not_active IP Right Cessation
- 1989-02-20 DE DE89200421T patent/DE68907965T2/en not_active Expired - Fee Related
- 1989-02-20 ES ES89200421T patent/ES2058467T3/en not_active Expired - Lifetime
- 1989-02-20 EP EP89200421A patent/EP0334407B1/en not_active Expired - Lifetime
- 1989-02-20 AT AT89200421T patent/ATE92308T1/en not_active IP Right Cessation
- 1989-02-20 JP JP1038475A patent/JP3044046B2/en not_active Expired - Lifetime
- 1989-02-22 AU AU30216/89A patent/AU620846B2/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5105100A (en) * | 1990-06-29 | 1992-04-14 | Nec Corporation | Easily and quickly testable master-slave flipflop circuit |
| JP2019154340A (en) * | 2018-03-14 | 2019-09-19 | 森永乳業株式会社 | Dried lactulose, edible composition, and production method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1319615C (en) | 1993-06-29 |
| DK72989D0 (en) | 1989-02-17 |
| ES2058467T3 (en) | 1994-11-01 |
| DE68907965D1 (en) | 1993-09-09 |
| IE62727B1 (en) | 1995-02-22 |
| US4931554A (en) | 1990-06-05 |
| AU620846B2 (en) | 1992-02-27 |
| NZ228021A (en) | 1991-04-26 |
| EP0334407A1 (en) | 1989-09-27 |
| DK72989A (en) | 1989-08-23 |
| AU3021689A (en) | 1989-08-24 |
| ATE92308T1 (en) | 1993-08-15 |
| IE890513L (en) | 1989-08-22 |
| ZA891266B (en) | 1989-11-29 |
| EP0334407B1 (en) | 1993-08-04 |
| IL89344A (en) | 1993-01-31 |
| DE68907965T2 (en) | 1993-12-23 |
| IL89344A0 (en) | 1989-09-10 |
| JP3044046B2 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK102996A (en) | Pankreatin preparations | |
| JPS63157938A (en) | Enzyme premix for feed and production thereof | |
| JPH023611A (en) | Method for manufacturing a solid composition of lacturose and a composition obtained by this method | |
| KR100926895B1 (en) | Method for preparing side chain amino acid-containing granules | |
| JPH02180814A (en) | Granulated composition and method thereof | |
| DE3141498C2 (en) | ||
| JPH07119172B2 (en) | Riboflavin granules without auxiliary agents | |
| DE69010676T2 (en) | METHOD FOR PRODUCING FINE FIBERS AND FINE FIBERS. | |
| JPH08116917A (en) | Brewing raw material manufacturing method | |
| DE3045488C2 (en) | ||
| JPH07144A (en) | Production of extract powder of mycelium of ganoderma lucidum karst. | |
| DE60007072T2 (en) | GRANULA FOR ORAL ADMINISTRATION, METHOD FOR THE PRODUCTION THEREOF, AND TABLETS PRODUCED FROM THE GRANULA | |
| US6322812B1 (en) | Pharmaceutical forms for the oral administration of mesna | |
| DE2638088B2 (en) | Use of sweet whey powder | |
| JPS62255407A (en) | Storage stable medicine and manufacture | |
| US3020204A (en) | Process for preparing augmentative intrinsic factor concentrate | |
| JPH02124894A (en) | Stabilized phytic acid composition | |
| CN110314148A (en) | A kind of preparation method of phosphoric acid hydrogen calcium tablet | |
| CN121421041A (en) | Functional milk powder and preparation method and application thereof | |
| KR880000040B1 (en) | Process for producing salts containing low sodium | |
| JPH0240035B2 (en) | BOSANTANSAN KARUSHIUMUHIRYONOSEIZOHOHO | |
| CN120204161A (en) | Flunixin meglumine granules and preparation method thereof | |
| CN117919293A (en) | Polyphenol lettuce liver-protecting composition and preparation method thereof | |
| JP2516542B2 (en) | Laxative-containing laxative composition | |
| EP0114199A2 (en) | Galenic form of amitriptyloxide, and process for its preparation |